The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Thought when I saw the numbers in the before noon RNS thought 51K shares was insignificant volume for shorting. Ahh so is 518K - trully significant now. Hope all shorts closed and we we're back up.
They can shut up now and not request for RNS to hope damp the sp like the previous Mon. one as they made their money for shorting.
Can't believe CB keep on drawing on funds/loans or placings all these years. Should have sold Manica years ago for £7m or £10m and pay shareholders with proceed.
Think he just keeping job for him to do & get paid.
Not showing in this site. Why Lse?
Other shares got their RNS today showing in their page.
Haha, Dimitry d'Moses leading us - Fantastic!!
And guys not good idea to set stop loss for this and other AIM shares (in fact even ftse shares in this climate).
MM need shares and they taken advantage - they got to do it this time as is last chance for them as with the sale offer confirmed they can't do it anymore.
Back up now.
Dimitry can't too. He's got inside info. all along and still is as a M&A officer. In fact he'll have more 1st hand info. as a M&A officer than anyone else. So for those debating whether Dimitry can sell or even buy? - NO!
-So for those who's trying to come up with some ideas to use this as a scare tactics - NO, Dimitry is more so on inside info. and he cannot trade on EUA and why would he? He's on EUA's final M&A end !